Martin Löwer
Translationale Onkologie an der Universitätsmedizin der Johannes Gutenberg-Universität Mainz
Martin Löwer works in Cancer Immunotherapy and Biomarkers, Immunotherapy and Immune Responses, Glioma Diagnosis and Treatment, vaccines and immunoinformatics approaches, Cancer Genomics and Diagnostics. Recorded institutional associations include University Medical Center of the Johannes Gutenberg University Mainz, Translationale Onkologie an der Universitätsmedizin der Johannes Gutenberg-Universität Mainz.
Inclusion identifies researchers whose recorded research contributions may inform their university’s understanding of its research community. It does not rank individual research quality or establish current employment.
Selected research works
Up to 100 highly cited works; DOI links open the original research. Counts reflect the collected record, not real-time citation totals.
Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer
2017 · 2,473 citationsMutant MHC class II epitopes drive therapeutic immune responses to cancer
2015 · 1,237 citationsActively personalized vaccination trial for newly diagnosed glioblastoma
2018 · 935 citationsExploiting the Mutanome for Tumor Vaccination
2012 · 810 citationsIdentification of neoantigens for individualized therapeutic cancer vaccines
2022 · 534 citationsKey Parameters of Tumor Epitope Immunogenicity Revealed Through a Consortium Approach Improve Neoantigen Prediction
2020 · 531 citationsImproving mRNA-Based Therapeutic Gene Delivery by Expression-Augmenting 3′ UTRs Identified by Cellular Library Screening
2018 · 362 citationsMyeloid Cell-Derived Reactive Oxygen Species Induce Epithelial Mutagenesis
2017 · 359 citationsTargeting immune checkpoints potentiates immunoediting and changes the dynamics of tumor evolution
2017 · 297 citationsHelicobacter pylori HtrA is a new secreted virulence factor that cleaves E‐cadherin to disrupt intercellular adhesion
2010 · 295 citationsHLA typing from RNA-Seq sequence reads
2012 · 270 citationsResponse definition criteria for ELISPOT assays revisited
2010 · 225 citationsMulti-Omics Characterization of the 4T1 Murine Mammary Gland Tumor Model
2020 · 210 citationsPrediction of Type III Secretion Signals in Genomes of Gram-Negative Bacteria
2009 · 118 citationsAutogene cevumeran with or without atezolizumab in advanced solid tumors: a phase 1 trial
2025 · 118 citationsDigital Genome-Wide ncRNA Expression, Including SnoRNAs, across 11 Human Tissues Using PolyA-Neutral Amplification
2010 · 117 citationsHLA and proteasome expression body map
2018 · 105 citationsA catalog of HLA type, HLA expression, and neo-epitope candidates in human cancer cell lines
2014 · 102 citationsPrediction of Extracellular Proteases of the Human Pathogen Helicobacter pylori Reveals Proteolytic Activity of the Hp1018/19 Protein HtrA
2008 · 84 citationsBioinformatics for Cancer Immunotherapy
2020 · 65 citationsAccurate detection of tumor-specific gene fusions reveals strongly immunogenic personal neo-antigens
2022 · 59 citationsInhibitors of Helicobacter pylori Protease HtrA Found by ‘Virtual Ligand’ Screening Combat Bacterial Invasion of Epithelia
2011 · 55 citationsAdhesion, Invasion, and Agglutination Mediated by Two Trimeric Autotransporters in the Human Uropathogen Proteus mirabilis
2010 · 52 citationsChallenges towards the realization of individualized cancer vaccines
2018 · 47 citationsMutanome Engineered RNA Immunotherapy: Towards Patient-Centered Tumor Vaccination
2015 · 42 citations
